TY - JOUR
T1 - Priorities and Treatment Preferences among Surgery-Naive Patients with Moderate to Severe Open-Angle Glaucoma
AU - Bicket, Amanda K.
AU - Le, Jimmy T.
AU - Yorkgitis, Carol
AU - Li, Tianjing
N1 - Funding Information:
Sponsored by the National Eye Institute, National Institutes of Health, Bethesda, Maryland (grant nos.: 5K12EY015025 [A.K.B.] and UG1EY020522 [T.L.]); and the U.S. Food and Drug Administration (grant no.: U01FD005942). Financial Disclosure(s): The author(s) have made the following disclosure(s): A.K.B.: Consultant – W. L. Gore & Associates, Inc. Obtained funding: N/A; Study was performed as part of the authors' regular employment duties. No additional funding was provided.
Publisher Copyright:
© 2020 American Academy of Ophthalmology
PY - 2020/9/1
Y1 - 2020/9/1
N2 - Purpose: To explore patients’ perspectives and experiences living with moderate to severe glaucoma through qualitative, semistructured interviews and to identify important benefits and risks that patients consider when choosing glaucoma treatments. Design: Semistructured, in-person qualitative interviews with a convenience sample of patients seen at the Johns Hopkins Wilmer Eye Institute. Participants: Surgery-naive patients 21 years of age or older with moderate to severe open-angle glaucoma seeking treatment at the Wilmer Eye Institute's Glaucoma Center of Excellence between August and December 2018. Methods: We conducted semistructured interviews with patients diagnosed with moderate to severe open-angle glaucoma, focusing on outcomes they prioritize when considering various treatment options. We used Atlas.ti software version 7.5.12 (Scientific Software Development GmbH, Berlin, Germany) to process interview transcripts and the framework approach to analyze the qualitative data. Main Outcome Measures: Patients’ descriptions of outcomes important to them in management of moderate to severe open-angle glaucoma. Results: Thirteen men and 15 women with a median age 67 years participated in the study. Compared with the mild-to-moderate glaucoma patients interviewed previously, these participants similarly emphasized (1) activities of daily living, (2) visual symptoms, (3) treatment burden, and (4) intraocular pressure (IOP) control, but unlike patients with milder disease, most related IOP control directly to (5) avoiding disease progression. Almost all (27/28) had also given significant thought to (6) surgical decision making and could describe how they would decide for or against a particular procedure. Finally, two thirds (18/28) expressed (7) significant fear and worry related to their glaucoma diagnosis. Conclusions: We identified outcomes that matter to patients who are undergoing treatment for moderate to severe glaucoma, many of which may serve as end points in clinical trials, such as functional independence in vision-dependent activities of daily living, avoidance of visual symptoms, and disease progression via maintenance of IOP control. We also observed that these patients have varied and nuanced perspectives on surgical management and its outcomes. It behooves providers and trial designers to consider these in future evaluations of new treatments for moderate to severe glaucoma.
AB - Purpose: To explore patients’ perspectives and experiences living with moderate to severe glaucoma through qualitative, semistructured interviews and to identify important benefits and risks that patients consider when choosing glaucoma treatments. Design: Semistructured, in-person qualitative interviews with a convenience sample of patients seen at the Johns Hopkins Wilmer Eye Institute. Participants: Surgery-naive patients 21 years of age or older with moderate to severe open-angle glaucoma seeking treatment at the Wilmer Eye Institute's Glaucoma Center of Excellence between August and December 2018. Methods: We conducted semistructured interviews with patients diagnosed with moderate to severe open-angle glaucoma, focusing on outcomes they prioritize when considering various treatment options. We used Atlas.ti software version 7.5.12 (Scientific Software Development GmbH, Berlin, Germany) to process interview transcripts and the framework approach to analyze the qualitative data. Main Outcome Measures: Patients’ descriptions of outcomes important to them in management of moderate to severe open-angle glaucoma. Results: Thirteen men and 15 women with a median age 67 years participated in the study. Compared with the mild-to-moderate glaucoma patients interviewed previously, these participants similarly emphasized (1) activities of daily living, (2) visual symptoms, (3) treatment burden, and (4) intraocular pressure (IOP) control, but unlike patients with milder disease, most related IOP control directly to (5) avoiding disease progression. Almost all (27/28) had also given significant thought to (6) surgical decision making and could describe how they would decide for or against a particular procedure. Finally, two thirds (18/28) expressed (7) significant fear and worry related to their glaucoma diagnosis. Conclusions: We identified outcomes that matter to patients who are undergoing treatment for moderate to severe glaucoma, many of which may serve as end points in clinical trials, such as functional independence in vision-dependent activities of daily living, avoidance of visual symptoms, and disease progression via maintenance of IOP control. We also observed that these patients have varied and nuanced perspectives on surgical management and its outcomes. It behooves providers and trial designers to consider these in future evaluations of new treatments for moderate to severe glaucoma.
UR - http://www.scopus.com/inward/record.url?scp=85091811426&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85091811426&partnerID=8YFLogxK
U2 - 10.1016/j.ogla.2020.05.003
DO - 10.1016/j.ogla.2020.05.003
M3 - Article
C2 - 32768363
AN - SCOPUS:85091811426
SN - 2589-4196
VL - 3
SP - 377
EP - 383
JO - Ophthalmology. Glaucoma
JF - Ophthalmology. Glaucoma
IS - 5
ER -